Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study
This study is ongoing, but not recruiting participants.
Sponsored by: National Eye Institute (NEI)
Information provided by: National Eye Institute (NEI)
ClinicalTrials.gov Identifier: NCT00000155
  Purpose

To describe the clinical course of keratoconus and to describe the relationships among its visual and physiological manifestations, including high- and low-contrast visual acuity, corneal curvature, slit lamp biomicroscopic findings, corneal scarring, and quality of life.

To identify risk factors and protective factors that influence the severity and progression of keratoconus.


Condition
Keratoconus

U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Longitudinal, Prospective Study

Further study details as provided by National Eye Institute (NEI):

Study Start Date: June 1995
Detailed Description:

Keratoconus is a bilateral, asymmetric, chronic, progressive ectasia of the cornea characterized by steepening and distortion of the cornea, thinning of the apical cornea, corneal scarring, and treatment-related sequelae, such as abrasions from contact lenses and surgical complications. Patients experience distorted vision that worsens with disease progression. Their vision is typically corrected with spectacles early in the disease and, later, with rigid contact lenses. Some patients eventually undergo corneal transplantation in one or both eyes. Keratoconus affects people in their prime earning years and profoundly affects their lives.

Previous large-scale studies of keratoconus have focused on incidence and prevalence, etiologies, or the clinical management of keratoconus. Few have characterized the course of the disease and risk factors for its progression in large samples of keratoconus patients. The incidence of vision-threatening corneal scarring in keratoconus is unknown. Patient's most frequent questions--how rapidly their keratoconus will progress, how bad their vision will become, whether they will need corneal surgery, how successful their contact lenses will be--cannot be answered on the basis of the current body of knowledge.

The need for a prospective, observational study of keratoconus patients is great. Results from this study will address keratoconus patient's unanswered questions and will enable eye care practitioners to manage this complex ocular disease better.

The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study is a multicenter, observational study of 1,209 keratoconus patients followed for 3 years.

Patients are examined annually. Study measures include visual acuity, patient-reported quality of life, manifest refraction, keratometry, photodocumentation of the cornea to identify central corneal scarring, photodocumentation of the flattest contact lens that just clears the cornea, slit lamp biomicroscopy, and corneal topography. In rigid contact lens wearers, the fluorescein pattern of the patient's habitual contact lenses is photodocumented.

Patients are examined at 15 clinical centers. The clinical centers enrolled 1,209 patients in 12 months.

  Eligibility

Ages Eligible for Study:   12 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Patients with keratoconus were eligible if they were at least 12 years old; had an irregular cornea as determined by keratometry, retinoscopy, or direct ophthalmoscopy in at least one eye; had Vogt's striae, Fleischer's ring, or corneal scarring characteristic of keratoconus in at least one eye; and planned to stay in the area for at least 3 years. They were ineligible if they had bilateral corneal transplants or bilateral nonkeratoconic eye disease (cataract, intraocular lenses, macular disease, or optic nerve disease other than glaucoma).

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000155

Locations
United States, California
University of California, Berkeley, School of Optometry
Berkeley, California, United States, 94720-2020
Southern California College of Optometry
Fullerton, California, United States, 92831
Jules Stein Eye Institute, University of California at Los Angeles
Los Angeles, California, United States, 90095-7003
United States, Florida
Nova Southeastern University, Health Professions Division, College of Optometry
Ft. Lauderdale, Florida, United States, 33328
United States, Illinois
University of Illinois at Chicago, Department of Ophthalmology and Visual Sciences
Chicago, Illinois, United States, 60612
United States, Indiana
Indiana University, School of Optometry
Bloomington, Indiana, United States, 47405-3680
United States, Missouri
University of Missouri-St. Louis, School of Optometry
St. Louis, Missouri, United States, 63121
United States, New York
SUNY State College of Optometry
New York, New York, United States, 10036-8003
United States, Ohio
University Hospitals of Cleveland, Department of Ophthalmology
Cleveland, Ohio, United States, 44106
The Ohio State University, College of Optometry
Columbus, Ohio, United States, 43210-1240
United States, Pennsylvania
Pennsylvania College of Optometry, The Eye Institute
Philadelphia, Pennsylvania, United States, 19141
Northeastern Eye Institute
Scranton, Pennsylvania, United States, 18503
United States, Utah
University of Utah, John Moran Eye Center
Salt Lake City, Utah, United States, 84132
United States, Wisconsin
Gundersen Lutheran
La Crosse, Wisconsin, United States, 54601
Sponsors and Collaborators
  More Information

Publications:
Study ID Numbers: NEI-57
Study First Received: September 23, 1999
Last Updated: June 23, 2005
ClinicalTrials.gov Identifier: NCT00000155  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Corneal Diseases
Eye Diseases
Keratoconus

ClinicalTrials.gov processed this record on January 15, 2009